BioSpace News Archive

Eton Pharmaceuticals, Inc today announced that it has acquired U.S. marketing rights to carglumic acid tablets.

Roswell Biotechnologies, Inc ., the molecular electronics company, announced today the formation of its Scientific Advisory Board (SAB).

Aerie Pharmaceuticals, Inc. announced today that its third quarter 2021 financial results will be released after the market closes on Thursday, November 4, 2021.

Insmed Incorporated today reported financial results for the third quarter ended September 30, 2021 and provided a business update.

Organon (NYSE: OGN), will release its third quarter 2021 financial results on November 11, 2021, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET.

Incyte (Nasdaq:INCY) today announced the validation of the European Marketing Authorization Application (MAA) for ruxolitinib cream

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), today announced members of the Company’s management team will be presenting at the following upcoming medical conferences and invites investors and the research community to attend virtually via webcast

Spero Therapeutics, Inc. (Nasdaq: SPRO), today announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA), seeking approval for tebipenem HBr tablets for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible microorganisms.

Global Blood Therapeutics, Inc. announced that it will report third quarter 2021 financial results on Thursday, November 4, 2021, after U.S. financial markets close.

PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the quarter ended September 30, 2021 by press release on Wednesday, November 10, 2021 at approximately 7:00 a.m. Eastern Time .